Molecular Stethoscope is an early stage, molecular diagnostics company engaged in transcriptomic research and development in San Diego, California.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $8.2M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | DCVC | dcvc.com/ |
| - | AAF Manage... | aaf.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.01.2017 | Seed | $8.2M | - |
Mentions in press and media 9
| Date | Title | Description |
| 07.06.2022 | Molecular Stethoscope, Inc. announces new investment from the Alzheimer's Drug Discovery Foundation | Investment by the ADDF will accelerate the translation of Molecular Stethoscope's cf-mRNA liquid biopsy technology platform into products and services for the diagnosis and management of Alzheimer's disease SOUTH SAN FRANCISCO, Calif., June... |
| 04.01.2022 | Molecular Stethoscope, Inc. establishes new Corporate Headquarters and Research & Development Laboratories in South San Francisco and appoints Gajus Worthington to its Board of Directors | SOUTH SAN FRANCISCO, Calif., Jan. 4, 2022 /PRNewswire/ -- Molecular Stethoscope, a leading Precision Medicine biotechnology company pioneering the next-generation cf-mRNA Liquid Biopsy, announced today that it has joined Verily Life Science... |
| 16.11.2021 | Molecular Stethoscope, Inc. Announces Presentation of Primary Sclerosing Cholangitis (PSC) Study at the AASLD Liver Meeting 2021 | Study results demonstrate the utility of the Company's Next-Generation cf-mRNA Liquid Biopsy Technology Platform for the characterization of PSC PALO ALTO, Calif., Nov. 16, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medic... |
| 29.09.2021 | Molecular Stethoscope, Inc. Announces Presentation at 16th Annual Sequencing to Function: Analysis and Applications for the Future Meeting | Presentation highlights a path forward to lead the development of the Company's clinical-grade Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform PALO ALTO, Calif., Sept. 29, 2021 /PRNewswire/ -- Molecular Ste... |
| 23.02.2021 | Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiology | |
| 14.12.2020 | Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances | |
| 05.01.2017 | Term Sheet — Thursday, January 5 | THE 21 BEST TECH IPOS of 2016, ETC Visions: SoftBank has been purposely opaque about many aspects of Vision Fund, its $100 billion (!) tech investment fund, in part, because the fund isn’t closed yet and general solicitation rules prevent i... |
| 05.01.2017 | Molecular Stethoscope Closes $8.2M Seed Funding | Molecular Stethoscope, Inc., a San Diego, CA-based biotechnology company developing novel blood-based early detection and disease monitoring tests, completed an $8.2m seed financing. Backers included DCVC (Data Collective), Pfizer Inc. (NYS... |
| 05.01.2017 | Molecular Stethoscope Raises $8.2M | San Diego-based Molecular Stethoscope, a biotechnology startup developing a blood-based, liquid biopsy platform for early detection and monitoring of disease, has raised $8.2M in a seed funding round. The funding came from Data Collective, ... |